期刊论文详细信息
BMC Nephrology
Peripheral artery disease in peritoneal dialysis and hemodialysis patients: single-center retrospective study in Taiwan
Chi-Feng Pan2  Mei-Ching Yeh4  Pi-Chu Jen4  Sheng-Fang Chiang4  Su-Mei Shen4  Li-Hua Chou4  Chih-Jen Wu3  Chun-Chuan Lee1 
[1] Division of Endocrinology and Metabolism, Department of Internal Medicine, Mackay Memorial Hospital, Taipei, Taiwan;Mackay Medicine, Nursing and Management College, Taipei, Taiwan;College of Medicine, Taipei Medical University, Taipei, Taiwan;Division of Hemodialysis and Peritoneal Dialysis, Department of Nursing, Mackay Memorial Hospital, Taipei, Taiwan
关键词: Peripheral artery disease;    Peritoneal dialysis;    Hemodialysis;    End-stage renal disease;    Cardiovascular disease;    Ankle-brachial pressure index (ABI);   
Others  :  1083111
DOI  :  10.1186/1471-2369-13-100
 received in 2012-05-04, accepted in 2012-08-27,  发布年份 2012
PDF
【 摘 要 】

Background

Peripheral artery disease (PAD) is a condition characterized by restricted blood flow to the extremities, and is especially common in the elderly. PAD increases the risk for mortality and morbidity in patients with end-stage renal disease (ESRD), especially those on hemodialysis (HD).

Methods

The records of 484 patients with end-stage renal disease who were on HD or peritoneal dialysis (PD) were reviewed. PAD was diagnosed based on the ankle-brachial pressure index (ABI). Demographic and clinical characteristics were analyzed.

Results

PAD had an overall prevalence of 18.2% and was significantly more common in HD patients (21.8%) than in PD patients (4.8%). Advanced age, diabetes mellitus, smoking, low parathyroid hormone level, elevated serum ferritin, elevated serum glucose, and low serum creatinine levels increased the risk for PAD. PAD was independently associated with advanced age, diabetes mellitus, duration of dialysis, low serum creatinine, and hyperlipidemia. PD patients had a significantly lower prevalence of PAD than HD patients, maybe due to their younger age and lower prevalence of diabetes mellitus in this present study.

Conclusions

The prevalence of PAD was greater in the HD group than the PD group. Most of the risk factors for PAD were specific to HD, and no analyzed factor was significantly associated with PAD in PD patients.

【 授权许可】

   
2012 Lee et al.; licensee BioMed Central Ltd.

【 预 览 】
附件列表
Files Size Format View
20141224195037107.pdf 270KB PDF download
Figure 1. 53KB Image download
【 图 表 】

Figure 1.

【 参考文献 】
  • [1]Foley RN, Parfrey PS, Sarnak MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998, 32(Suppl 3):S112-S119.
  • [2]O’Hare A, Johansen KJ: Lower-extremity peripheral arterial disease among patients with end-stage renal disease. J Am Soc Nephrol 2001, 12:2838-2847.
  • [3]Selvin E, Erlinger P: Prevalence of and risk factors for peripheral arterial disease in the United States. results from the national health and nutrition examination survey 1999–2000. Circulation 2004, 110:738-743.
  • [4]Hirsch AT, Criqui MH, Treat-Jacobson D, et al.: Peripheral arterial disease detection, awareness and treatment in primary care. JAMA 2001, 286:1317-1324.
  • [5]Rajagopalan S, Dellegrottaglie S, Furniss AL, et al.: Peripheral arterial disease in patients with end-stage renal disease-observations from the dialysis outcomes and practice patterns study (DOPPS). Circulation 2006, 114:1914-1922.
  • [6]Criqui MH, Langer RD, Fronek A: Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992, 326:381-386.
  • [7]Bartholomew JR, Olin JW: Pathophysiology of peripheral arterial disease and risk factors for its development. Cleve Clin J Med 2006, 73(suppl 4):S8-S14.
  • [8]O’Hare AM, Glidden DV, Fox CS, Hsu C: High revalence of peripheral arterial disease in persons with renal insufficiency: Results from the national health and nutrition examination survey 1999–2000. Circulation 2004, 109:320-323.
  • [9]Tian S-L, Murphy M, Han Q-F, Lu X-H, Wang T: Prevalence and risk factors for peripheral artery disease among patients on maintenance peritoneal dialysis. Blood Purif 2010, 30:50-55.
  • [10]Paraskevas KI, Kotsikoris I, Koupidid SA, Giannoukas AD, Mikhailidis DP: Ankle-brachial index: A marker of both peripheral arterial disease and systemic atherosclerosis as well as a predictor of vascular events. Angiology 2010, 61:521-523.
  • [11]Liu JH, Lin HH, Yang YF, et al.: Subclinical peripheral artery disease in patients undergoing peritoneal dialysis: risk factors and outcome. Perit Dial Int 2009, 29:64-71.
  • [12]Newman AB, Sutton-Tyrrell K, Vogt MT, Kuller LH: Morbidity and mortality in hypertensive adults with a low ankle/arm blood pressure index. JAMA 1993, 270:487-489.
  • [13]Suominen V, Rantanen T, Venermo M, Saarinen J, Salenius J: Prevalence and risk factors for PAD among patients with elevated ABI. Eur J Vasc Endovasc Surg 2008, 35:709-714.
  • [14]O’Hare AM, Hus C-Y, Baccehetti P, Johansen KL: Peripheral vascular disease risk factors among patients undergoing hemodialysis. J Am Soc Nephrol 2002, 13:497-503.
  • [15]Ouriel K, McDonnell AE, Metz CE, Zarins CK: Critical evaluation of stress testing in the diagnosis of peripheral vascular disease. Surgery 1982, 91:686-693.
  • [16]Yao ST, Hobbs JT, Irvine WT: Ankle systolic pressure measurements in arterial disease affecting the lower extremities. Br J Surg 1969, 56:676-679.
  • [17]Feringa HHH, Karagiannis SE, Schouten O, et al.: Prognostic significance of decline ankle-brachial index values in patients with suspected or known peripheral arterial disease. Eur J Vasc Surg 2007, 34:206-213.
  • [18]Guerrero A, Montes R, Munoz-Tero J, et al.: Peripheral arterial disease in patients with stages IV and V chronic renal failure. Nephrol Dial Transplant 2006, 21:3525-3531.
  • [19]Tsunoda K, Shimajiri Y, Morita S, et al.: Chronic kidney disease has a more powerful impact on peripheral arterial disease than metabolic syndrome in Japanese type 2 diabetic patients. Metab Syndr Relat Disord 2009, 7:323-326.
  • [20]Depalma RG, Hayes VW, Chow BK, et al.: Ferritin levels, inflammatory biomarkers, and mortality in peripheral arterial disease: a substudy of the iron (Fe) and atherosclerosis study (FeAST) trial. J Vasc Surg 2010, 51:1498-1503.
  • [21]Muir RL: Peripheral arterial disease: Pathophysiology, risk factors, diagnosis, treatment, and prevention. J Vasc Nurs 2009, 27:26-30.
  • [22]Subramaniam T, Nang EE, Lim SC, et al.: Distribution of ankle-brachial index and the risk factors of peripheral artery disease in a multi-ethnic Asian population. Vasc Med 2011, 16:87-95.
  文献评价指标  
  下载次数:14次 浏览次数:4次